Patent and SPC holders can stop parallel imports from new EU states to old ones if equivalent protection wasn’t available for patents at the time of filing but was for SPCs, CJEU rules in Pfizer v Orifarm
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
Patrick assists with editorial agenda management, and regularly reports on patent-related issues, including FRAND, supplementary protection certificates and patent eligibility, as well as trade secrets. He also chairs industry events and produces conference newspapers.
VLSI case halted in Delaware; Netflix sues Bridgerton rip-off; Ex-GSK scientist escapes damages; US Copyright Office debuts new software; Abbvie scores Humira patent thicket win; Russia tables bill on illegal blocking of copyrighted content